MSCM
IBB icon

McElhenny Sheffield Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-142,013
Closed -$24M – 114
2026
Q1 		$24M Sell
142,013
-8,490
-6% -$1.45M 5.94% 4
2025
Q4 		$25.4M Buy
+150,503
New +$24.4M 6.18% 5

Other funds holding IBB

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

McElhenny Sheffield Capital Management's IBB Position: Q2 2026 in Review

McElhenny Sheffield Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 142,013 shares — an estimated $24M sold.

McElhenny Sheffield Capital Management first reported a position in IBB in Q4 2025 and held it in 2 quarters. The position peaked at $25.4M in Q4 2025. 285 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • McElhenny Sheffield Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • McElhenny Sheffield Capital Management sold 142,013 iShares Biotechnology ETF shares in Q2 2026, an estimated $24M.
  • McElhenny Sheffield Capital Management first reported a position in iShares Biotechnology ETF in Q4 2025 and held it in 2 quarters.
  • McElhenny Sheffield Capital Management's iShares Biotechnology ETF position peaked at $25.4M in Q4 2025.
  • 285 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on McElhenny Sheffield Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.